121 related articles for article (PubMed ID: 15855824)
1. Overexpression of Polo-like kinase 1 is a common and early event in pancreatic cancer.
Weichert W; Schmidt M; Jacob J; Gekeler V; Langrehr J; Neuhaus P; Bahra M; Denkert C; Dietel M; Kristiansen G
Pancreatology; 2005; 5(2-3):259-65. PubMed ID: 15855824
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.
Weichert W; Schmidt M; Gekeler V; Denkert C; Stephan C; Jung K; Loening S; Dietel M; Kristiansen G
Prostate; 2004 Aug; 60(3):240-5. PubMed ID: 15176053
[TBL] [Abstract][Full Text] [Related]
3. [Polo like kinase 1 expression and prognostic value in gastric carcinomas].
Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):70-2. PubMed ID: 17253180
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.
Weichert W; Denkert C; Schmidt M; Gekeler V; Wolf G; Köbel M; Dietel M; Hauptmann S
Br J Cancer; 2004 Feb; 90(4):815-21. PubMed ID: 14970859
[TBL] [Abstract][Full Text] [Related]
5. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
Reagan-Shaw S; Ahmad N
FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 1 as a new target for non-Hodgkin's lymphoma treatment.
Liu L; Zhang M; Zou P
Oncology; 2008; 74(1-2):96-103. PubMed ID: 18547964
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.
Weichert W; Kristiansen G; Winzer KJ; Schmidt M; Gekeler V; Noske A; Müller BM; Niesporek S; Dietel M; Denkert C
Virchows Arch; 2005 Apr; 446(4):442-50. PubMed ID: 15785925
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase 1 expression in medullary carcinoma of the thyroid: its relationship with clinicopathological features.
Ito Y; Nakamura Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A
Pathobiology; 2005; 72(4):186-90. PubMed ID: 16127294
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas.
Jang YJ; Kim YS; Kim WH
Int J Oncol; 2006 Sep; 29(3):589-94. PubMed ID: 16865274
[TBL] [Abstract][Full Text] [Related]
10. [Expression of checkpoint kinase 1 and polo-like kinase 1 and its clinicopathological significance in benign and malignant lesions of the stomach].
Yao H; Yang Z; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1080-4. PubMed ID: 21051833
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
Spänkuch-Schmitt B; Wolf G; Solbach C; Loibl S; Knecht R; Stegmüller M; von Minckwitz G; Kaufmann M; Strebhardt K
Oncogene; 2002 May; 21(20):3162-71. PubMed ID: 12082631
[TBL] [Abstract][Full Text] [Related]
12. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1).
Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P
Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415
[TBL] [Abstract][Full Text] [Related]
13. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
Kanaji S; Saito H; Tsujitani S; Matsumoto S; Tatebe S; Kondo A; Ozaki M; Ito H; Ikeguchi M
Oncology; 2006; 70(2):126-33. PubMed ID: 16645325
[TBL] [Abstract][Full Text] [Related]
14. Polo-like kinase 1 expression is a prognostic factor in human colon cancer.
Weichert W; Kristiansen G; Schmidt M; Gekeler V; Noske A; Niesporek S; Dietel M; Denkert C
World J Gastroenterol; 2005 Sep; 11(36):5644-50. PubMed ID: 16237758
[TBL] [Abstract][Full Text] [Related]
15. [Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].
Chen XJ; Wu LM; Xu XB; Feng XW; Xie HY; Zhang M; Shen Y; Wang WL; Liang TB; Zheng SS
Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1354-8. PubMed ID: 18241575
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas.
Dibb M; Han N; Choudhury J; Hayes S; Valentine H; West C; Sharrocks AD; Ang YS
BMC Res Notes; 2015 Nov; 8():676. PubMed ID: 26576650
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
18. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L
Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215
[TBL] [Abstract][Full Text] [Related]
19. Polo-like kinase 1 (PLK1) expression is associated with cell proliferative activity and cdc2 expression in malignant lymphoma of the thyroid.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2004; 24(1):259-63. PubMed ID: 15015605
[TBL] [Abstract][Full Text] [Related]
20. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
